Already at best price
Nexovas TM 25 Tablet ER
Cilnidipine (10mg) + Telmisartan (40mg) + Metoprolol Succinate (23.75mg)
Macleods Pharmaceuticals Pvt Ltd
Hypertension
₹141.80
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
₹141.80
Active composition
Cilnidipine 10 mg
+2 more active ingredients
How It Works
Cilnidipine inhibits L-type and N-type calcium channels in vascular smooth muscle, leading to vasodilation and reduced blood pressure.
Telmisartan selectively blocks angiotensin II receptors, leading to vasodilation and decreased blood pressure.
Metoprolol Succinate blocks beta-1 adrenergic receptors, leading to decreased heart rate and contractility, thereby lowering blood pressure.
Medicine Strength
10 mg
All Active Ingredients
Cilnidipine10 mg
Telmisartan40 mg
Metoprolol Succinate23.75 mg
Uses & Benefits
Medical applications
Blood Pressure
Nexovas TM 25 Tablet ER is a combined antihypertensive medication, designed for the management of hypertension in adults. The tablet contains Cilnidipine (10mg), a calcium channel blocker; Metoprolol Succinate (23.75mg), a beta-blocker; and Telmisartan (40mg), an angiotensin II receptor blocker. The extended-release formulation allows for once-daily administration, enhancing patient compliance. The combination therapy aims to reduce blood pressure by multiple mechanisms, potentially offering improved efficacy and reduced side effects compared to monotherapy. As with any medication, Nexovas TM 25 Tablet ER should be used under medical supervision, and patients should be advised of the potential for drug interactions and adverse effects.
Dosage & How to Use
How to use Nexovas TM Tablet ER Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Nexovas TM 25 Tablet ER is to be taken with food.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
✓Only 2.3% reported effects
Common Side Effects
Headache8%
Nausea5%
Higher
Lower
Safety Advice
Alcohol
It is unsafe to consume alcohol with Nexovas TM 25 Tablet ER.
High Risk
Pregnancy
Nexovas TM 25 Tablet ER is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Medical Advice
Driving
Nexovas TM 25 Tablet ER may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Exercise Caution
Liver
Nexovas TM 25 Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Nexovas TM 25 Tablet ER may be needed. Please consult your doctor. Use of Nexovas TM 25 Tablet ER is not recommended in patients with severe liver disease.
Regular Checkup
Breastfeeding
Information regarding the use of Nexovas TM 25 Tablet ER during breastfeeding is not available. Please consult your doctor.
Consult Doctor
Kidney
There is limited information available on the use of Nexovas TM 25 Tablet ER in patients with kidney disease. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Nexovas TM 25 Tablet ER
Nexovas TM 25 Tablet ER
1 / 5
Rx RequiredSchedule H
Nexovas TM 25 Tablet ER
Cilnidipine (10mg) + Metoprolol Succinate (23.75mg) + Telmisartan (40mg)
₹141.80
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
Cheaper alternative availability
Not Foundfor this medicine
Already at the Best Price
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
Cilnidipine 10 mg
+2 more active ingredients
How It Works
Cilnidipine inhibits L-type and N-type calcium channels in vascular smooth muscle, leading to vasodilation and reduced blood pressure.
Telmisartan selectively blocks angiotensin II receptors, leading to vasodilation and decreased blood pressure.
Metoprolol Succinate blocks beta-1 adrenergic receptors, leading to decreased heart rate and contractility, thereby lowering blood pressure.
Medicine Strength
10 mg
All Active Ingredients
Cilnidipine10 mg
Telmisartan40 mg
Metoprolol Succinate23.75 mg
Uses & Benefits
Medical applications
Blood Pressure
Nexovas TM 25 Tablet ER is a combined antihypertensive medication, designed for the management of hypertension in adults. The tablet contains Cilnidipine (10mg), a calcium channel blocker; Metoprolol Succinate (23.75mg), a beta-blocker; and Telmisartan (40mg), an angiotensin II receptor blocker. The extended-release formulation allows for once-daily administration, enhancing patient compliance. The combination therapy aims to reduce blood pressure by multiple mechanisms, potentially offering improved efficacy and reduced side effects compared to monotherapy. As with any medication, Nexovas TM 25 Tablet ER should be used under medical supervision, and patients should be advised of the potential for drug interactions and adverse effects.
Dosage & How to Use
How to use Nexovas TM Tablet ER Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Nexovas TM 25 Tablet ER is to be taken with food.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
✓Only 2.3% reported effects
Common Side Effects
Headache8%
Nausea5%
Higher
Lower
Safety Advice
Alcohol
It is unsafe to consume alcohol with Nexovas TM 25 Tablet ER.
High Risk
Pregnancy
Nexovas TM 25 Tablet ER is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Medical Advice
Driving
Nexovas TM 25 Tablet ER may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Exercise Caution
Liver
Nexovas TM 25 Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Nexovas TM 25 Tablet ER may be needed. Please consult your doctor. Use of Nexovas TM 25 Tablet ER is not recommended in patients with severe liver disease.
Regular Checkup
Breastfeeding
Information regarding the use of Nexovas TM 25 Tablet ER during breastfeeding is not available. Please consult your doctor.
Consult Doctor
Kidney
There is limited information available on the use of Nexovas TM 25 Tablet ER in patients with kidney disease. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Nexovas TM 25 Tablet ER
